Pharmacological Treatment of Alcohol Cravings.

alcohol craving randomi* controlled blind*

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
15 Aug 2023
Historique:
received: 22 05 2023
revised: 03 08 2023
accepted: 04 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

(1) Background: The treatment of substance addiction is challenging and has persisted for decades, with only a few therapeutic options. Although there are some recommendations for specific treatments for Alcohol Use Disorder (AUD), there is no specific medication used to treat alcohol cravings, which could benefit millions of patients that are suffering from alcoholism. Cravings, or the urge to use drugs, refer to the desire to experience the effects of a previously experienced psychoactive substance. (2) Methods: We included original studies of alcohol abuse or dependence extracted from a controlled, blind, pharmacological treatment study which presented measures and outcomes related to alcohol cravings. (3) Results: Specific drugs used for the treatment of alcoholism, such as Naltrexone and Acamprosate, have had the best results in relieving craving symptoms, as well as promoting abstinence. Baclofen and anticonvulsants such as Gabapentin and Topiramate have shown good results in promoting abstinence and the cessation of cravings. (4) Conclusions: Specific drugs used for the treatment of alcoholism to obtain the best results can be considered the gold standard for promoting abstinence and relieving cravings. Anticonvulsants and Baclofen also had good results, with these medications being considered as second-line ones. Varenicline is an option for alcohol dependents who also concomitantly ingest tobacco.

Identifiants

pubmed: 37626562
pii: brainsci13081206
doi: 10.3390/brainsci13081206
pmc: PMC10452441
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Alcohol Clin Exp Res. 2007 May;31(5):775-82
pubmed: 17378918
JAMA Intern Med. 2014 Jan;174(1):70-7
pubmed: 24190578
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):53-62
pubmed: 26356398
Acta Psychiatr Scand. 1983 Aug;68(2):100-10
pubmed: 6624506
Psychopharmacology (Berl). 2001 Feb;154(1):23-7
pubmed: 11292002
Alcohol Clin Exp Res. 1992 Aug;16(4):673-6
pubmed: 1326902
ACS Chem Neurosci. 2020 Dec 2;11(23):3850-3859
pubmed: 31287661
Alcohol Clin Exp Res. 2012 Feb;36(2):351-60
pubmed: 21919922
Addiction. 2006 Oct;101(10):1451-62
pubmed: 16968347
Alcohol Clin Exp Res. 2015 Nov;39(11):2189-99
pubmed: 26414337
J Clin Psychiatry. 2015 Feb;76(2):181-8
pubmed: 25742205
Curr Opin Pharmacol. 2006 Feb;6(1):108-13
pubmed: 16376147
Alcohol Clin Exp Res. 1999 Feb;23(2):230-5
pubmed: 10069551
J Clin Psychiatry. 2007 Nov;68(11):1691-700
pubmed: 18052562
Alcohol Clin Exp Res. 1996 Jun;20(4):780-4
pubmed: 8800399
Epilepsia. 2007 Oct;48(10):1842-9
pubmed: 17521347
Alcohol Clin Exp Res. 2002 Sep;26(9):1381-7
pubmed: 12351933
Lancet. 2003 May 17;361(9370):1677-85
pubmed: 12767733
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Clin Psychopharmacol. 2007 Aug;27(4):344-51
pubmed: 17632217
Alcohol Clin Exp Res. 2002 Dec;26(12):1816-22
pubmed: 12500105
Eur J Neurosci. 2004 Sep;20(6):1566-76
pubmed: 15355323
Alcohol Clin Exp Res. 2019 Jan;43(1):135-146
pubmed: 30462837
J Clin Psychopharmacol. 2012 Aug;32(4):558-62
pubmed: 22722516
Neuropsychopharmacology. 2005 Dec;30(12):2245-53
pubmed: 15956985
Alcohol Clin Exp Res. 2013 Mar;37(3):484-9
pubmed: 23025690
Psychopharmacology (Berl). 1996 Nov;128(2):206-15
pubmed: 8956382
J Altern Complement Med. 2000 Feb;6(1):45-8
pubmed: 10706235
Alcohol Clin Exp Res. 1996 Apr;20(2):307-12
pubmed: 8730222
J Psychiatr Res. 2005 Sep;39(5):545-51
pubmed: 15992564
Alcohol Clin Exp Res. 2007 Jul;31(7):1188-94
pubmed: 17511748
J Clin Psychopharmacol. 2004 Aug;24(4):421-8
pubmed: 15232334
Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93
pubmed: 11093966
Alcohol Clin Exp Res. 2012 Aug;36(8):1309-10
pubmed: 22823576
J Addict Med. 2019 Jan/Feb;13(1):7-22
pubmed: 30096077
Psychopharmacology (Berl). 2002 Apr;160(4):408-13
pubmed: 11919668
Alcohol Clin Exp Res. 2003 Jul;27(7):1142-9
pubmed: 12878920
Alcohol Alcohol. 2010 Sep-Oct;45(5):449-55
pubmed: 20595193
J Clin Psychiatry. 2003;64 Suppl 8:5-8
pubmed: 12892535
Eur J Drug Metab Pharmacokinet. 1982;7(2):81-91
pubmed: 6749509
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(1):33-43
pubmed: 32105267
Alcohol Alcohol. 2019 May 1;54(3):272-278
pubmed: 30977770
Alcohol Clin Exp Res. 2018 Oct;42(10):2011-2021
pubmed: 30055046
J Clin Psychopharmacol. 2002 Dec;22(6):592-8
pubmed: 12454559
Alcohol Clin Exp Res. 2009 Feb;33(2):255-63
pubmed: 18945226
JAMA Psychiatry. 2016 Oct 01;73(10):1056-1063
pubmed: 27627782
Alcohol Clin Exp Res. 2009 Feb;33(2):264-72
pubmed: 19032582
J Clin Psychopharmacol. 2009 Dec;29(6):584-9
pubmed: 19910725
Addict Biol. 2022 Mar;27(2):e13116
pubmed: 34856641
Brain Res. 2009 Dec 11;1305 Suppl:S2-6
pubmed: 19799882
Neuropsychopharmacology. 2011 May;36(6):1178-86
pubmed: 21289601
Arch Gen Psychiatry. 1992 Nov;49(11):876-80
pubmed: 1345133
Cochrane Database Syst Rev. 2018 Apr 24;4:CD008581
pubmed: 29688573
Methods Find Exp Clin Pharmacol. 1985 Apr;7(4):175-7
pubmed: 2991678
Drug Alcohol Depend. 2013 Dec 1;133(2):440-6
pubmed: 23906999
Psychopharmacology (Berl). 2011 Nov;218(1):89-99
pubmed: 21318567
BMC Clin Pharmacol. 2011 Jul 26;11:10
pubmed: 21787433
Nat Med. 1995 Apr;1(4):337-41
pubmed: 7585063
Alcohol Clin Exp Res. 2004 May;28(5):736-45
pubmed: 15166648
Pharmacopsychiatry. 2008 Mar;41(2):72-8
pubmed: 18311688
Clin Pharmacol Ther. 1991 Jul;50(1):96-106
pubmed: 1855357
Int J Environ Res Public Health. 2009 Jun;6(6):1917-29
pubmed: 19578468
Biochim Biophys Acta. 2016 Oct;1863(10):2422-35
pubmed: 26828774
J Addict Med. 2013 Jul-Aug;7(4):277-86
pubmed: 23728065
Alcohol Clin Exp Res. 2019 Jan;43(1):158-169
pubmed: 30403402
Alcohol Clin Exp Res. 2010 Nov;34(11):1849-57
pubmed: 20662805
Alcohol Clin Exp Res. 2002 Oct;26(10):1545-52
pubmed: 12394288
Channels (Austin). 2010 Nov-Dec;4(6):490-6
pubmed: 21150315
Alcohol Alcohol. 2002 Sep-Oct;37(5):504-8
pubmed: 12217947
J Clin Psychopharmacol. 2014 Feb;34(1):149-52
pubmed: 24346753
Addict Biol. 2016 Jul;21(4):904-14
pubmed: 26037245
Curr Pharm Des. 2022;28(27):2241-2259
pubmed: 35747956
Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41
pubmed: 12634260
J Clin Psychiatry. 1990 Feb;51(2):68-82
pubmed: 2404964
J Subst Abuse Treat. 2015 May;52:24-30
pubmed: 25572706
Drugs. 1985;30 Suppl 1:13-24
pubmed: 2994984
Addiction. 2018 Dec;113(12):2205-2213
pubmed: 29968397
Addict Biol. 2005 Sep;10(3):289-92
pubmed: 16109592
Am J Addict. 2001 Summer;10(3):258-68
pubmed: 11579624
Am J Psychiatry. 1999 Nov;156(11):1758-64
pubmed: 10553740
Clin Pharm. 1984 May-Jun;3(3):273-80
pubmed: 6329589
J Subst Abuse Treat. 1994 May-Jun;11(3):253-8
pubmed: 8072054
Epilepsy Res. 1998 Feb;29(3):233-49
pubmed: 9551785
Addiction. 2018 Jan;113(1):6-14
pubmed: 28710873
Neurosci Lett. 2018 Nov 1;686:133-139
pubmed: 30213620

Auteurs

Matheus Cheibub David Marin (MCD)

Perdizes Institute (IPer), Clinics Hospital of the Medical School (HCFMUSP), University of São Paulo, São Paulo 05021-001, Brazil.
Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.

Maria Olívia Pozzolo Pedro (MOP)

Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.
Department of Psychiatry, Medical School, University of São Paulo, São Paulo 05403-903, Brazil.

Giuliana Perrotte (G)

Department of Neuroscience, Medical School, FMABC University Center, Santo André 09060-870, Brazil.

Anderson S Martins-da-Silva (AS)

Department of Psychiatry, Medical School, University of São Paulo, São Paulo 05403-903, Brazil.

Dangela L S Lassi (DLS)

Perdizes Institute (IPer), Clinics Hospital of the Medical School (HCFMUSP), University of São Paulo, São Paulo 05021-001, Brazil.

Israel Kanaan Blaas (IK)

Perdizes Institute (IPer), Clinics Hospital of the Medical School (HCFMUSP), University of São Paulo, São Paulo 05021-001, Brazil.
Department of Neuroscience, Medical School, FMABC University Center, Santo André 09060-870, Brazil.

Fernando Ikeda Castaldelli (FI)

Medical School Catanduva (FAMECA), Padre Albino University Center, Catanduva 15809-144, Brazil.

Maria Beatriz Brisola Dos Santos (MB)

Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.

Guilherme Trevizan Kortas (GT)

Perdizes Institute (IPer), Clinics Hospital of the Medical School (HCFMUSP), University of São Paulo, São Paulo 05021-001, Brazil.
Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.
Department of Psychiatry, Medical School, University of São Paulo, São Paulo 05403-903, Brazil.

Marcela Waisman Campos (MW)

Department of Cognitive Neurology, Neuropsychiatry, and Neuropsychology, Fleni, Buenos Aires C1428AQK, Argentina.

Julio Torales (J)

Department of Medical Psychology, School of Medical Sciences, Universidad Nacional de Asunción, San Lorenzo 111454, Paraguay.
Regional Institute of Health Research, Universidad Nacional de Caaguazú, Coronel Oviedo 050106, Paraguay.
School of Health Sciences, Universidad Sudamericana, Pedro Juan Caballero 130112, Paraguay.

Antonio Ventriglio (A)

Department of Experimental Medicine, Medical School, University of Foggia, 71100 Foggia, Italy.

Cintia de Azevedo-Marques Périco (CA)

Department of Neuroscience, Medical School, FMABC University Center, Santo André 09060-870, Brazil.

André B Negrão (AB)

Perdizes Institute (IPer), Clinics Hospital of the Medical School (HCFMUSP), University of São Paulo, São Paulo 05021-001, Brazil.

Kae Leopoldo (K)

Department of Psychiatry, Medical School, University of São Paulo, São Paulo 05403-903, Brazil.

Arthur Guerra de Andrade (AG)

Perdizes Institute (IPer), Clinics Hospital of the Medical School (HCFMUSP), University of São Paulo, São Paulo 05021-001, Brazil.
Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.
Department of Psychiatry, Medical School, University of São Paulo, São Paulo 05403-903, Brazil.
Department of Neuroscience, Medical School, FMABC University Center, Santo André 09060-870, Brazil.

André Malbergier (A)

Perdizes Institute (IPer), Clinics Hospital of the Medical School (HCFMUSP), University of São Paulo, São Paulo 05021-001, Brazil.
Department of Psychiatry, Medical School, University of São Paulo, São Paulo 05403-903, Brazil.

João Maurício Castaldelli-Maia (JM)

Hospital Sírio-Libanês, São Paulo 01308-050, Brazil.
Department of Psychiatry, Medical School, University of São Paulo, São Paulo 05403-903, Brazil.
Department of Neuroscience, Medical School, FMABC University Center, Santo André 09060-870, Brazil.

Classifications MeSH